Background: Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott Laboratories trades an average of 6.4 million shares per day and has a market cap of $103 billion.
52-Week Range: $52.05 to $72.47Book Value: $15.60 Price-to-Book Ratio: 4.2 Earnings Payout Percentage: 48% Abbott pays a large $2.04 annually in dividend payments. The yield is 3.3% and makes Abbott an almost must own for retirees trying to make it on investment income. In the last month, shares have pulled back 2.6%. The new discount in price provides the buying dip for exposure to a portfolio-performing 3.3% yield. Abbott is in a strong bullish trend. The shares have moved 21% higher over the last 52 weeks. Expect more upside as analysts are calling for a price target of $71.36. Short-sellers are next to impossible to find, and 0.6% of the float is short based on the last reported numbers. Of course, I wouldn't include a stock that the smart money believes has more downside than upside potential. ABT Payout Ratio TTM data by YCharts